- Home
- LEGN vs ACHC Comparison
LEGN vs ACHC Comparison
Compare LEGN & ACHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEGN
- ACHC
- Stock Information
- Founded
- LEGN 2014
- ACHC 2005
- Country
- LEGN United States
- ACHC United States
- Employees
- LEGN N/A
- ACHC N/A
- Industry
- LEGN Biotechnology: Pharmaceutical Preparations
- ACHC Medical Specialities
- Sector
- LEGN Health Care
- ACHC Health Care
- Exchange
- LEGN Nasdaq
- ACHC Nasdaq
- Market Cap
- LEGN 7.0B
- ACHC 2.1B
- IPO Year
- LEGN 2020
- ACHC N/A
- Fundamental
- Price
- LEGN $27.78
- ACHC $26.15
- Analyst Decision
- LEGN Strong Buy
- ACHC Strong Buy
- Analyst Count
- LEGN 13
- ACHC 10
- Target Price
- LEGN $75.67
- ACHC $52.25
- AVG Volume (30 Days)
- LEGN 1.5M
- ACHC 3.2M
- Earning Date
- LEGN 05-13-2025
- ACHC 05-12-2025
- Dividend Yield
- LEGN N/A
- ACHC N/A
- EPS Growth
- LEGN N/A
- ACHC N/A
- EPS
- LEGN N/A
- ACHC 2.04
- Revenue
- LEGN $728,303,000.00
- ACHC $3,156,417,000.00
- Revenue This Year
- LEGN $65.96
- ACHC $7.90
- Revenue Next Year
- LEGN $52.55
- ACHC $8.58
- P/E Ratio
- LEGN N/A
- ACHC $12.79
- Revenue Growth
- LEGN 112.46
- ACHC 5.48
- 52 Week Low
- LEGN $29.27
- ACHC $20.36
- 52 Week High
- LEGN $60.87
- ACHC $82.41
- Technical
- Relative Strength Index (RSI)
- LEGN 29.61
- ACHC 54.98
- Support Level
- LEGN $30.25
- ACHC $24.41
- Resistance Level
- LEGN $33.30
- ACHC $28.48
- Average True Range (ATR)
- LEGN 1.78
- ACHC 1.34
- MACD
- LEGN -0.57
- ACHC 0.63
- Stochastic Oscillator
- LEGN 5.19
- ACHC 67.55
About LEGN Legend Biotech Corporation
Legend Biotech Corp is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of novel cell therapies for oncology and other indications. The firm's lead product candidate, LCAR-B38M/JNJ-4528, is a chimeric antigen receptor, or CAR, T cell therapy for the treatment of multiple myeloma. Geographically, the company generates a majority of its revenue from the United States of America. The company generates revenue from License and Collaboration revenue.
About ACHC Acadia Healthcare Company Inc.
Acadia Healthcare Co Inc acquires and develops behavioral healthcare facilities. Acute inpatient psychiatric facilities and specialty treatment facilities contribute the vast majority of Acadia's revenue in the United States. The company's revenue is derived from services rendered to patients for inpatient psychiatric and substance abuse care, outpatient psychiatric care, and adolescent residential treatment.